Baidu
map

Lancet Diab & Endo:五分之二的美国人或患II型糖尿病

2014-08-15 佚名 生物谷

近日,刊登在国际杂志The Lancet Diabetes & Endocrinology上的一篇研究报道中,来自美国疾病预防控制中心的研究人员表示,五分之二的美国成年人一生中都会有患上II型糖尿病的风险,而对于西班牙人和黑人妇女来讲患II型糖尿病的风险或许更高,这主要是因为其缺乏一定的体力活动及体重过重导致的。该项研究的结果是研究人员对人们进行调查并且对60万名死亡个体的资料进行分

近日,刊登在国际杂志The Lancet Diabetes & Endocrinology上的一篇研究报道中,来自美国疾病预防控制中心的研究人员表示,五分之二的美国成年人一生中都会有患上II型糖尿病的风险,而对于西班牙人和黑人妇女来讲患II型糖尿病的风险或许更高,这主要是因为其缺乏一定的体力活动及体重过重导致的。

该项研究的结果是研究人员对人们进行调查并且对60万名死亡个体的资料进行分析后所得的,研究者表示,患II型糖尿病的终生危险,或者说是非胰岛素型依赖性糖尿病,在1985-1989年间,男性患者的比例为20%,女性患者的比例为27%,而截至到2000-2001年间,男性患者的比例增长到了40%,而女性患者的比例增长到了39%。

而对于西班牙人及非西班牙裔的黑人妇女来讲,其患病风险都超过了50%;近些年来由于患者得到了更好的健康护理,因此同一时期内患者的死亡率反而下降了,这就意味着糖尿病患者的生存时间比以前更长了。

随着糖尿病患者数量的不断增加以及其生存时间的延长,患者对于健康服务和治疗成本的需求就开始与日俱增了;据世界卫生组织数据显示,全球目前有3.47亿糖尿病患者,截至2010年已经有大约300万人死亡了。全世界的糖尿病患者中有90%的患者都是II型糖尿病患者,世界卫生组织专家表示,这在很大程度上是由体重过重及体力活动严重缺乏引起的。

糖尿病会损伤心脏、血管、眼睛及肾脏等机体组织,而且会增加患心脏病及中风的风险,来自多伦多大学的研究者Lorraine Lipscombe说道,糖尿病可以通过日常的生活习惯的改变来预防,预防的措施包括对城市规划的优化、食物销售的政策、个人的工作情况以及学校环境等,这些都可以使得个体改变其生活方式,使得生活方式更为健康,从而降低II型糖尿病的发病风险。

原始出处:

Dr Edward W Gregg PhD a , Xiaohui Zhuo PhD a, Yiling J Cheng PhD a, Ann L Albright PhD a, Prof K M Venkat Narayan MD b, Theodore J Thompson MS a.Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985—2011: a modelling study.The Lancet Diabetes & Endocrinology, Early Online Publication, 13 August 2014.doi:10.1016/S2213-8587(14)70161-5

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=20642, encodeId=885f2064288, content=糖尿病肾病进展风险的关系没有发现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:23:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827861, encodeId=a600182e86137, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Dec 25 13:11:00 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636929, encodeId=0920163692992, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Mar 04 11:11:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910777, encodeId=cc8a1910e7760, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Thu Jul 30 21:11:00 CST 2015, time=2015-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429671, encodeId=264614296e17a, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9592, encryptionId=9a8d9592b0, topicName=II型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7914226234, createdName=lsj629, createdTime=Sun Aug 17 00:11:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11137, encodeId=d7a01113e28, content=中国人1/3,彼此彼此, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=59.46.163.34, createdTime=Sat Aug 16 00:15:00 CST 2014, time=2014-08-16, status=1, ipAttribution=)]
    2015-04-11 x35042875

    糖尿病肾病进展风险的关系没有发现。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=20642, encodeId=885f2064288, content=糖尿病肾病进展风险的关系没有发现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:23:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827861, encodeId=a600182e86137, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Dec 25 13:11:00 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636929, encodeId=0920163692992, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Mar 04 11:11:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910777, encodeId=cc8a1910e7760, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Thu Jul 30 21:11:00 CST 2015, time=2015-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429671, encodeId=264614296e17a, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9592, encryptionId=9a8d9592b0, topicName=II型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7914226234, createdName=lsj629, createdTime=Sun Aug 17 00:11:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11137, encodeId=d7a01113e28, content=中国人1/3,彼此彼此, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=59.46.163.34, createdTime=Sat Aug 16 00:15:00 CST 2014, time=2014-08-16, status=1, ipAttribution=)]
    2014-12-25 howi
  3. [GetPortalCommentsPageByObjectIdResponse(id=20642, encodeId=885f2064288, content=糖尿病肾病进展风险的关系没有发现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:23:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827861, encodeId=a600182e86137, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Dec 25 13:11:00 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636929, encodeId=0920163692992, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Mar 04 11:11:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910777, encodeId=cc8a1910e7760, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Thu Jul 30 21:11:00 CST 2015, time=2015-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429671, encodeId=264614296e17a, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9592, encryptionId=9a8d9592b0, topicName=II型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7914226234, createdName=lsj629, createdTime=Sun Aug 17 00:11:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11137, encodeId=d7a01113e28, content=中国人1/3,彼此彼此, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=59.46.163.34, createdTime=Sat Aug 16 00:15:00 CST 2014, time=2014-08-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=20642, encodeId=885f2064288, content=糖尿病肾病进展风险的关系没有发现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:23:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827861, encodeId=a600182e86137, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Dec 25 13:11:00 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636929, encodeId=0920163692992, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Mar 04 11:11:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910777, encodeId=cc8a1910e7760, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Thu Jul 30 21:11:00 CST 2015, time=2015-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429671, encodeId=264614296e17a, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9592, encryptionId=9a8d9592b0, topicName=II型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7914226234, createdName=lsj629, createdTime=Sun Aug 17 00:11:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11137, encodeId=d7a01113e28, content=中国人1/3,彼此彼此, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=59.46.163.34, createdTime=Sat Aug 16 00:15:00 CST 2014, time=2014-08-16, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=20642, encodeId=885f2064288, content=糖尿病肾病进展风险的关系没有发现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:23:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827861, encodeId=a600182e86137, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Dec 25 13:11:00 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636929, encodeId=0920163692992, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Mar 04 11:11:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910777, encodeId=cc8a1910e7760, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Thu Jul 30 21:11:00 CST 2015, time=2015-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429671, encodeId=264614296e17a, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9592, encryptionId=9a8d9592b0, topicName=II型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7914226234, createdName=lsj629, createdTime=Sun Aug 17 00:11:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11137, encodeId=d7a01113e28, content=中国人1/3,彼此彼此, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=59.46.163.34, createdTime=Sat Aug 16 00:15:00 CST 2014, time=2014-08-16, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=20642, encodeId=885f2064288, content=糖尿病肾病进展风险的关系没有发现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:23:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827861, encodeId=a600182e86137, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Dec 25 13:11:00 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636929, encodeId=0920163692992, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Mar 04 11:11:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910777, encodeId=cc8a1910e7760, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Thu Jul 30 21:11:00 CST 2015, time=2015-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429671, encodeId=264614296e17a, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9592, encryptionId=9a8d9592b0, topicName=II型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7914226234, createdName=lsj629, createdTime=Sun Aug 17 00:11:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11137, encodeId=d7a01113e28, content=中国人1/3,彼此彼此, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=59.46.163.34, createdTime=Sat Aug 16 00:15:00 CST 2014, time=2014-08-16, status=1, ipAttribution=)]
    2014-08-16 59.46.163.34

    中国人1/3,彼此彼此

    0

相关资讯

Diabetologia:咖啡或降低T2DM发病率又添一新证

研究发现,在过去四年中,如果平均每天的咖啡摄入量增加了一杯半,其Ⅱ型糖尿病的发病率则会减少11%,这无疑降低了Ⅱ型糖尿病的发病几率。咖啡和茶摄入量的增加与Ⅱ型糖尿病的发病率减少有关,但人们对这种联系内在的机理却知之甚少,直到现在,这个谜团终于被解开了。 作者就四年中咖啡和茶摄入量的变化与随后四年中Ⅱ型糖尿病发病率之间的联系进行了调查。 最近发布在欧洲糖尿病研究协会《糖尿病学》(Diabetol

Nature:单次注射FGF1有望成为治疗糖尿病新药

糖尿病分两型,I型糖尿病是因免疫系统攻击胰岛细胞、损伤其产生胰岛素功能所致,而胰岛素可维持血糖在正常水平;II型糖尿病与超重、缺乏锻炼引起的胰岛素抵抗有关,胰岛细胞可继续产生胰岛素,但机体不能有效利用这种激素,导致循环血糖升高。过去10年时间内,II型糖尿病发病率明显上升,属慢性疾病的II型糖尿病可导致严重的健康问题。这种疾病无治愈方法,但通过药物及生活方式(包括饮食、减肥及规律运动)调整

Nat Med:遏制肥胖&II型糖尿病?只需抑制关键信号路径即可

近日,一项发表在国际著名杂志Nature Medicine上的研究报告中,来自普渡大学的研究人员通过研究发现,一种对机体发育和细胞交流非常关键的信号—Notch信号路径在肥胖和II型糖尿病的发病过程中扮演着重要的角色。研究者Shihuan Kuang说道,阻断小鼠脂肪组织中的Notch信号会引发白色脂肪细胞转化成为米色脂肪细胞,这项研究或可揭示,抑制脂肪细胞中的Notch信号路径就可以减少肥

Diabetes Obes Metab:II型糖尿病患者或比非糖尿病患者寿命更长

近日,来自卡迪夫大学的研究人员通过研究发现,接受药物治疗的II型糖尿病患者或许比非糖尿病患者的寿命更长,相关研究刊登于国际杂志Diabetes,Obesity and Metabolism上。 文章中,研究人员对18万人进行了一项大规模的研究,结果发现药物二甲双胍可以用于控制糖尿病患者的机体血糖水平,二甲双胍是人们熟知的一种具有抗癌特性的药物,其可以给非糖尿病患者带来健康的预防作用。 这项研究

Nat Genet:罕见基因突变可防止患II型糖尿病

据美国媒体报道,新发表的一项研究发现,一种罕见的基因突变可以防止人们患上II型糖尿病,可将患病风险降低了三分之二,如此显着的效果为制药公司开辟了一个新的前景:开发一种药物来模仿这种基因突变的效果。据报道,这项新研究是以15万人的基因测试结果为基础进行的。产生胰岛素的胰细胞使用的一个基因遭到这种突变的破坏。有这种基因变异的人产生的胰岛素比正常人略多,一生中的血糖水平都较普通人略低。美国两家公司表示,

JAMA Intern Med:降Ⅱ型糖尿病老年患者血糖或弊大于利

一份发表在《JAMA·内科学杂志》上的新研究表明,对患有Ⅱ型糖尿病的老年患者来说,降低血糖水平的药物可能“弊大于利”。Ⅱ型糖尿病以胰岛素抵抗为特点,这会导致高血糖水平。随着时间发展,高血糖会导致肾脏、眼睛或者心脏疾病,神经损伤或中风。有时这种情况可以通过饮食改变来控制,但很多Ⅱ型糖尿病患者还是需要药物治疗(例如胰岛素或二甲双胍)来帮他们降低血糖,用以减轻糖尿病并发症的风险。来自英国伦敦大学、密歇根

Baidu
map
Baidu
map
Baidu
map